Terms: = Lung cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
159 results:
1. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
2. Adult Pulmonary Blastoma: A Case Report with Spectrum of Rare Manifestations.
Parkhi M; Ahuja N; Kumar D; Basher RK; Singh N; Singh H; Bal A
Turk Patoloji Derg; 2024; 40(1):63-68. PubMed ID: 38235566
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Genomic Analysis of Patients With Non-Small-Cell lung cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
Wang HY; Ho CC; Lin YT; Liao WY; Chen CY; Shih JY; Yu CJ
JCO Precis Oncol; 2024 Jan; 8():e2300314. PubMed ID: 38190582
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
[TBL] [Abstract] [Full Text] [Related]
5. Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell lung cancer.
Chong AL; Thorner P; Ellis M; Swensen J; Benlimame N; Fiset PO; Gatalica Z; Evans MG; Foulkes WD
Am J Surg Pathol; 2024 Feb; 48(2):221-229. PubMed ID: 38050371
[TBL] [Abstract] [Full Text] [Related]
6. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer.
Sunaga N; Kaira K; Shimizu K; Tanaka I; Miura Y; Nakazawa S; Ohtaki Y; Kawabata-Iwakawa R; Sato M; Girard L; Minna JD; Hisada T
Thorac Cancer; 2024 Jan; 15(2):131-141. PubMed ID: 38014454
[TBL] [Abstract] [Full Text] [Related]
7. Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (ctnnb1) synergizes with cisplatin in lung cancer.
Tang Y; Sun Z; Wu S; Zhang C; Zhang Y; Cao Y
Biomed Pharmacother; 2023 Dec; 168():115828. PubMed ID: 37925939
[TBL] [Abstract] [Full Text] [Related]
8. Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and ctnnb1 mutations.
Kunishige M; Takeuchi E
Thorac Cancer; 2023 Dec; 14(34):3419-3420. PubMed ID: 37920971
[TBL] [Abstract] [Full Text] [Related]
9. ctnnb1 somatic mutations drive Wnt pathway activation in a case of incidental intranodal palisaded myofibroblastoma.
Moreno de Juan G; Montes Moreno S
Rev Esp Patol; 2023; 56(4):279-283. PubMed ID: 37879826
[TBL] [Abstract] [Full Text] [Related]
10. Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19.
Chatterjee S; Sanjeev BS
Microb Pathog; 2023 Dec; 185():106386. PubMed ID: 37865274
[TBL] [Abstract] [Full Text] [Related]
11. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
[TBL] [Abstract] [Full Text] [Related]
12. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
13. Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages.
Ho H; Yu SL; Chen HY; Yuan SS; Su KY; Hsu YC; Hsu CP; Chuang CY; Chang YH; Li YC; Cheng CL; Chang GC; Yang PC; Li KC
Lung Cancer; 2023 Oct; 184():107352. PubMed ID: 37657238
[TBL] [Abstract] [Full Text] [Related]
14. An oncogenic ctnnb1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
Kim Y; Ahn B; Yoon S; Lee G; Kim D; Chun SM; Kim HR; Jang SJ; Hwang HS
PLoS One; 2023; 18(6):e0287256. PubMed ID: 37347751
[TBL] [Abstract] [Full Text] [Related]
15. ctnnb1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract] [Full Text] [Related]
16. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant ctnnb1 mutations.
Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
[TBL] [Abstract] [Full Text] [Related]
17. β-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism.
Kramer ED; Tzetzo SL; Colligan SH; Hensen ML; Brackett CM; Clausen BE; Taketo MM; Abrams SI
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 37092550
[TBL] [Abstract] [Full Text] [Related]
18. Uterine MEIS1::NCOA2 Fusion Sarcoma With lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
19. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
[TBL] [Abstract] [Full Text] [Related]
20. PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC.
Kim DE; Shin SB; Kim CH; Kim YB; Oh HJ; Yim H
Theranostics; 2023; 13(3):1198-1216. PubMed ID: 36793862
[No Abstract] [Full Text] [Related]
[Next]
